Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$500M |
| 2 |
Arista Networks
ANET
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$271M |
| 4 |
Eli Lilly
LLY
|
+$271M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$495M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$388M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$369M |
| 5 |
Mastercard
MA
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Consumer Discretionary | 9.99% |
| 3 | Financials | 9.73% |
| 4 | Industrials | 7.81% |
| 5 | Healthcare | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Honda
HMC
$42.3B
| $13M | 0.02% |
+450,462
| New | +$13.1M |
|
827
CALL
AXIS Capital
AXS
$7.25B
| $13M | 0.02% |
+125,000
| New | +$12.4M |
|
828
Werner Enterprises
WERN
$2.26B
| $13M | 0.02% |
+474,140
| New | +$13M |
|
829
GDS Holdings
GDS
$6.36B
| $13M | 0.02% |
424,255
-5,845
| -1% | -$148K |
|
830
Globant
GLOB
$1.71B
| $13M | 0.02% |
142,623
+117,219
| +461% | +$12.5M |
|
831
CALL
Nucor
NUE
$55.5B
| $13M | 0.02% |
100,000
-322,000
| -76% | -$37.6M |
|
832
Trevi Therapeutics
TRVI
$2.58B
| $12.9M | 0.02% |
2,354,402
+595,783
| +34% | +$3.71M |
|
|
833
PUT
Eli Lilly
LLY
$1.11T
| $12.9M | 0.02% |
16,500
-27,000
| -62% | -$21M |
|
834
CALL
Zscaler
ZS
$28.5B
| $12.8M | 0.02% |
40,900
+28,200
| +222% | +$7.03M |
|
|
PLGO
835
Pelagos Insurance Capital
PLGO
$2.05B
| $12.8M | 0.02% |
772,764
+157,878
| +26% | +$2.62M |
|
836
Verisk Analytics
VRSK
$24.7B
| $12.7M | 0.02% |
+40,905
| New | +$12.4M |
|
837
Bank of America
BAC
$436B
| $12.7M | 0.02% |
268,155
-2,644,784
| -91% | -$111M |
|
838
CALL
Etsy
ETSY
$7.99B
| $12.7M | 0.02% |
252,600
+180,400
| +250% | +$8.97M |
|
|
EXAS
839
PUT
DELISTED
Exact Sciences
EXAS
| $12.6M | 0.02% |
+238,000
| New | +$12.1M |
|
|
840
CALL
Mastercard
MA
$525B
| $12.6M | 0.02% |
22,500
+300
| +1% | +$166K |
|
841
CALL
Elevance Health
ELV
$87.3B
| $12.6M | 0.02% |
32,500
-400
| -1% | -$161K |
|
|
842
PUT
Elevance Health
ELV
$87.3B
| $12.6M | 0.02% |
32,500
| – | – |
|
843
PUT
Affirm
AFRM
$25.7B
| $12.6M | 0.02% |
182,700
-130,200
| -42% | -$6.75M |
|
|
CHYM
844
Chime Financial
CHYM
$12.4B
| $12.6M | 0.02% |
+365,843
| New | +$12.1M |
|
845
Valmont Industries
VMI
$9.29B
| $12.6M | 0.02% |
+38,610
| New | +$11.8M |
|
846
IMAX
IMAX
$3B
| $12.6M | 0.02% |
+449,497
| New | +$11.7M |
|
847
CALL
Williams Companies
WMB
$86.8B
| $12.6M | 0.02% |
+200,000
| New | +$11.8M |
|
848
HubSpot
HUBS
$12.2B
| $12.5M | 0.02% |
22,494
-55,283
| -71% | -$32.4M |
|
|
ELME
849
Elme Communities
ELME
$149M
| $12.5M | 0.02% |
786,349
+492,558
| +168% | +$7.83M |
|
|
SNDK
850
CALL
Sandisk
SNDK
$219B
| $12.5M | 0.02% |
+275,000
| New | +$10.5M |
|
Similar funds
Dmitry Balyasny's Q2 2025 Portfolio in Review
As of Q2 2025, Dmitry Balyasny held 3,510 positions worth $66.4B, up 9.8% from $60.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Dmitry Balyasny's Q2 2025 filing shows 779 new, 864 increased, 1,015 reduced and 774 closed positions. Its largest new stake was Arista Networks: 3,646,977 shares worth $373M. The largest sale was iShares Core S&P 500 ETF, an estimated $495M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
- Dmitry Balyasny's largest Q2 2025 buy was Arista Networks: 3,646,977 shares worth $373M.
- Dmitry Balyasny added most to Brown & Brown in Q2 2025, an estimated $500M increase.
- Dmitry Balyasny's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $495M.
- Dmitry Balyasny fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2025, selling an estimated $369M.
- Dmitry Balyasny's ten largest holdings make up 13% of its $66.4B portfolio in Q2 2025.
- Dmitry Balyasny opened 779 new positions and closed 774 in Q2 2025.
- Dmitry Balyasny's portfolio value rose 9.8% quarter-over-quarter to $66.4B.
Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.